Medicine | Page 290 of 378 | SpiritIndia.com

Arthritis :: Turmeric supplements show promise in treating arthritis

More than 40 percent of arthritis sufferers in the U.S. report using complementary and alternative medicine, including dietary supplements, and the use of alternative remedies has increased since the FDA issued health warnings about anti-inflammatory drugs such as Celebrex. However, the effectiveness of many supplement ingredients has not been adequately studied. To complicate the matter, over-the-counter supplements are not regulated in the same way as drugs and their composition can vary widely. A new study published in the November 2006 issue of Arthritis & Rheumatism examined the effect and mechanism of turmeric (a botanical supplement long thought to have anti-inflammatory properties) on arthritis.

Flu :: Employee flu vaccination days planned at Penn State Hershey Medical Center

The employee health department at Penn State Hershey Medical Center and Penn State College of Medicine plans several campus-wide vaccination days for any employee interested in receiving the flu shot. Vaccines will be given on a first-come, first-serve basis, starting Oct. 30.

Influenza :: Good medicines for flu, influenza in alternative medicines

“Friends, as the winters are coming, they are bringing influenza with them. So, be prepared to fight the disease and know about it,” Dr. Poonam Singhal. Influenza, also called grippe or flu, an acute contagious viral infection characterized by inflammation of the respiratory tract and by fever, chills, muscular pain, and prostration, with cough, cold, sneezings, intense frontal headache, pain and aches in joints, fever (100 deg. F to 105 deg. F), nausea, etc.

Asthma :: Asthma symptoms linked to soot particles from diesel trucks in South Bronx

Soot particles spewing from the exhaust of diesel trucks constitute a major contributor to the alarmingly high rates of asthma symptoms among school-aged children in the South Bronx, according to the results of a five-year study by researchers at New York University?s School of Medicine and Robert F. Wagner Graduate School of Public Service.

Allergy :: Key enzyme involved in allergic disease identified

A research team has identified a key enzyme responsible for triggering a chain of events that results in allergic reaction, according to new study findings published this week in Nature Immunology. The work by researchers from Virginia Commonwealth University, the Hospital for Special Surgery and Weill Cornell Medical College in New York sets the stage for development of new strategies and target therapies that control allergic disease – the sixth leading cause of chronic disease in the United States.

Breast Implants :: Stem cells from fat for breast reconstruction

Breast cancer survivors might one day avoid the prospect of invasive breast reconstruction surgery, opting instead for an approach that would involve using stem cells derived from their own fat, suggest University of Pittsburgh researchers who are studying the potential these cells may have for regenerating new breast tissue.

Crohn’s Disease :: Gene found for crohn’s disease – hope for better therapy in inflammatory bowel diseases

A consortium of American and Canadian researchers report in Science Express, a rapid online publication by the journal Science, the discovery of a new genetic link to Crohn’s disease. While most of the mutations in the gene, which codes for a receptor in a major inflammatory pathway, are strongly associated with Crohn?s, surprisingly, one type of mutation appears to confer significant protection. The finding, say the researchers, points to a crucial target for drugs that might better manage Crohn?s disease and ulcerative colitis.

Hepatitis :: PEG-INTRON, peginterferon and REBETOL, ribavirin in Hepatitis C — Schering-Plough

Schering-Plough reported data from EPIC3, a large ongoing clinical study, showing that retreatment with PEG-INTRON(R) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy can result in sustained virologic response(1) (SVR) in patients with chronic hepatitis C who failed previous treatment with any alpha interferon-based combination therapy, including peginterferon regimens. In this study, 56 percent of patients who had undetectable virus (HCV-RNA) after 12 weeks went on to achieve SVR with a 48-week course of therapy. Of the first 1,354 patients retreated, approximately 38 percent had undetectable virus at week 12. Importantly, patients who did not have undetectable virus at 12 weeks had little chance of achieving SVR. Overall, 23 percent of patients achieved SVR.

ADHD :: Lilly’s Strattera, atomoxetine effective in treating ADHD in children and adolescents

New data suggest that Strattera? (atomoxetine HCl) improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder, like dyslexia. Results were announced at a meeting of child and adolescent psychiatrists.

HIV :: Laurie Garrett warns Libya on accused health workers

In an essay published urgently in the international open access journal PloS Medicine, Pulitzer Prize winning author Laurie Garrett warns that if Libya proceeds with the executions of six foreign health workers accused of infecting children with HIV, the appalling injustice will threaten health workers worldwide and endanger their patients in the poorest parts of the world.